AMGN Summary

  1. NASDAQ
  2. >
  3. AMGN
TickerAMGN
DescriptionAMGEN INC
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees23,400
Next Earnings DateOctober 28th, 2020
Ex-Dividend DateNovember 13th, 2020
Yield2.79513%
Dividend$1.60
IV33.244675%
IV Percentile77th
IV Rank26.60%
IV Skew2.372380
IV Skew Percentile20th
IV Skew SentimentBullish
Option Volume5,250
Volume2,104,204
Price$227.16
Previous Close$227.98
52-Week High$264.97
52-Week Low$177.05
50-Day Moving Avg.$244.12
200-Day Moving Avg.$232.13
10-Day Avg. Volume2,526,801
20-Day Avg. Volume2,665,737
30-Day Avg. Volume2,652,128
3-Month Avg. Volume2,670,017
PE18.69143
EPS$12.25
Outstanding Shares585,694,000
Float584,401,373
Market Capitalization$134,106,303,699
CurrencyUSD
UpdatedOctober 23rd, 2020